Genghis Lloyd-Harris

Directeur/Membre du Conseil chez Avillion LLP

Profil

Genghis Lloyd-Harris currently works at Avillion LLP, as Director, Abingworth Avillion Blocker Ltd., as Director, Nouscom AG, as Director, Nouscom Srl, as Director, and Abingworth Management Ltd., as Managing Partner from 2004.
Dr. Lloyd-Harris also formerly worked at Galapagos Biotech Ltd., as Non-Executive Director, Novexel SA, as Director, Solexa, Inc., as Director, Healthcare Brands International Ltd., as Director, Synosia Therapeutics, Inc., as Director, Gensight Biologics SA, as Director from 2013 to 2018, Wilson Therapeutics AB, as Independent Director, Ipsen Bioinnovation Ltd., as Director, Synosia Therapeutics AG, as Member-Management Board, Credit Suisse Securities (Europe) Ltd., as Analyst, and Abingworth LLP, as Managing Partner.
Dr. Lloyd-Harris received his doctorate degree from the University of Melbourne, doctorate degree from The University of Liverpool, and Masters Business Admin degree from Harvard Business School.

Postes actifs de Genghis Lloyd-Harris

Sociétés	Poste	Début
Avillion LLP	Directeur/Membre du Conseil	-
Abingworth Management Ltd.	Corporate Officer/Principal	01/01/2004
Abingworth Avillion Blocker Ltd.	Directeur/Membre du Conseil	-
Nouscom AG	Directeur/Membre du Conseil	-
Nouscom Srl	Directeur/Membre du Conseil	-

Anciens postes connus de Genghis Lloyd-Harris

Sociétés	Poste	Fin
GENSIGHT BIOLOGICS S.A.	Directeur/Membre du Conseil	16/03/2018
Solexa, Inc.	Directeur/Membre du Conseil	03/08/2006
Healthcare Brands International Ltd.	Directeur/Membre du Conseil	-
WILSON THERAPEUTICS AB	Directeur/Membre du Conseil	-
░░░░░ ░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-